S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RLAY Relay Therapeutics Inc

2.72

0.00 (0.00%)

Pre Market

Last Updated: 03:29:26

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From Mar 2025 to Mar 2025

Click Here for more Relay Therapeutics Charts.

Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Relay Therapeutics Charts.

Relay Therapeutics Inc News

Form 144 - Report of proposed sale of securities
Thursday 27 March 2025 (4 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 26 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (1 month ago) • Edgar (US Regulatory)

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Wednesday 26 February 2025 (1 month ago) • GlobeNewswire Inc.

Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Monday 24 February 2025 (1 month ago) • GlobeNewswire Inc.

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025
Wednesday 19 February 2025 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 5 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 29 January 2025 (2 months ago) • Edgar (US Regulatory)

More Relay Therapeutics Inc News Articles

Clean Vision (QB)

North Bay Resources (PK)

Northwest Biotherapeutics (QB)

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

Accredited Solutions (PK)

Elite Pharmaceuticals (QB)

Lightwave Logic

Liquidmetal Technologies (QB)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions